Skip to main content
HeartCited

Resveratrol Figures

5 figures from peer-reviewed research

All Berberine Calcium Coenzyme Q10 (CoQ10) Folate (Vitamin B9) Lycopene Magnesium Potassium Quercetin Resveratrol Selenium Vitamin D
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 1 Cardiac aging and heart failure (HF). Lifetime molecular and cellular stresses such as genomic, epigenetic, oxidative, autophagic, inflammatory and regenerative stresses, along with the accumulation of senescent cells, drive cardiac aging and lead
Figure 1 Diagram

Comprehensive diagram of cardiac aging mechanisms leading to heart failure, depicting how genomic, epigenetic, oxidative, autophagic, and inflammatory stresses drive structural changes including left ventricular hypertrophy and myocardial fibrosis.

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues.

Figure 2 Systemic aging and heart failure (HF). Systemic aging fuels HF, with cardiac, vascular, metabolic and inflammaging as major contributors. HF-associated molecular mechanisms—cardiac, vascular, metabolic and inflammaging—are summarized along with obs
Figure 2 Diagram

Systemic aging pathways fueling heart failure, summarizing cardiac, vascular, metabolic, and inflammaging mechanisms alongside their associated molecular changes and clinical phenotypes.

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues.

Figure 3
Figure 3 Diagram

Molecular mechanisms or therapeutic targets related to age-associated heart failure, covering topics such as senescent cell accumulation, RAAS dysregulation, and potential anti-aging interventions.

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues.

Figure 4
Figure 4 Diagram

Molecular mechanisms or therapeutic targets related to age-associated heart failure, covering topics such as senescent cell accumulation, RAAS dysregulation, and potential anti-aging interventions.

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues.

Fig. 1 Dietary reference intakes. Schematic diagram illustrating the risks of nutrient inadequacy and adverse effects
Figure 3 Diagram

Fig. 1 Dietary reference intakes.

Dietary supplements and prevention of preeclampsia.